T cell Activation Marker HLA-DR Reflects Tacrolimus-Associated Immunosuppressive Burden and BK Viremia Risk After Kidney Transplantation – An Observational Cohort Study

Kidney transplantation (KT) is the current treatment of choice in patients with end-stage kidney disease. Immunosuppression is required to prevent acute rejection but is associated with a high incidence of adverse events. The immunosuppressive burden substantially differs between individuals, necess...

Повний опис

Бібліографічні деталі

Автори:	Simon Aberger, Max Schuller, Agnes A. Mooslechner, Konstantin A. Klötzer, Barbara Prietl, Verena Pfeifer, Alexander H. Kirsch, Alexander R. Rosenkranz, Katharina Artinger, Kathrin Eller
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2025-07-01
Серія:	Transplant International
Предмети:	immune monitoring immunosuppression kidney transplantation translational nephrology personalized medicine
Онлайн доступ:	https://www.frontierspartnerships.org/articles/10.3389/ti.2025.14443/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!